Monoclonal Antibody Therapy for COVID-19 in Dallas
You May Qualify for mAb Therapy if You Are at High Risk for Severe COVID-19 Illness
Have you tested positive for the COVID-19 virus within the last 10 days? If you’re in a high-risk health group for worse health complications due to an underlying condition like cancer, COPD, heart disease, pregnancy, advanced age, and so on, you may be eligible for monoclonal antibody therapy to help put you on the road to a more rapid recovery.
What Is Monoclonal Antibody Therapy?
The purpose of monoclonal antibody therapy is to prevent COVID-19 hospitalizations, reduce viral loads, and lessen symptom severity in patients with active infections. Specific individuals are prioritized for this treatment based on personal situations determined by how much of a threat the virus poses to their health.
The U.S. Food and Drug Administration (FDA) gave Emergency Use Authorization (EUA) monoclonal antibody therapy for COVID-19 treatment, a drug called Bebtelovimab, starting in February 2022. Treatment is delivered via IV infusion, and most patients tolerate the one-dose treatment well. The appointment takes about 1 to 3 hours and is administered in our comfortable ER setting.
What Are Monoclonal Antibodies?
Any time your body fights off bacteria or viruses, it naturally produces antibodies to do so. However, those it makes to fight off coronavirus are not very effective, so laboratory scientists had to step in to find a way to help these patients. People who test positive for the COVID-19 virus can get a jumpstart on healing with monoclonal antibody therapy, as these laboratory-created antibodies are specially designed to be highly potent when neutralizing this specific strain of coronavirus.
Am I Eligible for Monoclonal Antibody Treatment?
You may be eligible for monoclonal antibody treatment if you have had a positive test result for COVID-19 within the last 10 days and the following apply:
- You are at high risk for developing severe COVID-19 and
- You have had a positive COVID-19 test but have not yet been admitted to a hospital and
- You are 12+ years of age and weigh at least 88 pounds
Come to Advance ER in Dallas for Monoclonal Antibody Therapy for COVID-19
At Advance ER, we are proud to be at the frontlines helping those affected by COVID-19, just as we have been since the outset of the pandemic. We provide COVID-19 testing, treatment, and monoclonal antibody therapy to qualified patients from our trusted emergency medicine professionals. If you are struggling with COVID-19 symptoms, you should seek immediate medical attention. Our staff can quickly and accurately test you for the virus and provide a specialized treatment plan should you test positive. We are eager to keep current with all scientific developments to protect the general population and keep you safe from this virus that preys on the most vulnerable among us.
For more information about COVID-19 treatments such as monoclonal antibody therapy in Dallas, get in touch with our team today by calling (214) 494-8222 or reach out online for a quick reply.